GlassScriptPhysician profile
Susan M Sweeney
NPI 1033192976
$955.87
in general payments reported to CMS, 2019-2025
16 companies · $603 in 2025
The $603 reported for 2025 was less than what a typical Dermatology provider received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $52.23 · 2020: $31.06 · 2021: $70.58 · 2022: $112 · 2024: $86.83 · 2025: $603.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $615 · Education: $75.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $615.16 |
| Education | $75.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $153.90 | 2025 | Tremfya |
| Incyte Corporation | $134.76 | 2021-2025 | Opzelura |
| Abbvie INC. | $121.81 | 2021-2025 | |
| Pfizer INC. | $98.55 | 2019-2025 | |
| Novartis Pharmaceuticals Corporation | $84.02 | 2019-2025 | |
| Ucb, INC. | $69.10 | 2025 | Bimzelx |
| Regeneron Healthcare Solutions, INC. | $58.98 | 2021-2025 | Dupixent |
| Lilly USA, LLC | $57.06 | 2025 | Ebglyss, Taltz |
| Organon LLC | $33.37 | 2025 | |
| Prugen, INC. Pharmaceuticals | $31.06 | 2020 | |
| Lnhc, INC | $23.94 | 2025 | Zelsuvmi |
| Helsinn Therapeutics (U.S.), INC. | $22.69 | 2025 | Valchlor |
| Verrica Pharmaceuticals INC. | $18.54 | 2025 | Ycanth |
| Botanix Sb INC | $17.84 | 2025 | Sofdra |
| Galderma Laboratories, L.P. | $16.32 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arcutis Biotherapeutics, INC. | $13.93 | 2025 | Zoryve |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Susan Sweeney listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.